Michael Shapiro is the inaugural Fred M. Parrish Professor of Cardiology and Molecular Medicine at Wake Forest University where he is on faculty in the Section of Cardiovascular Medicine. After completing a cardiology fellowship, Michael spent two additional years in a clinical and research fellowship focused on advanced cardiovascular imaging at Massachusetts General Hospital.  Since that time, his clinical and research focus has been on lipids, atherosclerosis, and prevention of cardiovascular disease. He is currently Director of the Center for Prevention of Cardiovascular Disease at Wake Forest University School of Medicine. He also serves as the president of the American Society for Preventive Cardiology (ASPC) co-director of the NIH T32 Fellowship program in Cardiovascular Disease Epidemiology and Prevention. 

Michael has received funding from the NIH, AHA, and several foundations. He has published extensively in the areas of atherosclerosis imaging, lipid disorders, and preventive cardiology. The scope of his research spans translational science, cardiovascular epidemiology, and clinical trials of novel lipid modulating therapeutics. He is a member of numerous boards and national committees and is currently president of the American Society for Preventive Cardiology (ASPC).